Amyloid-beta statuses prediction with free water MR imaging features in Alzheimer's disease using machine learning models

利用机器学习模型,基于自由水磁共振成像特征预测阿尔茨海默病中淀粉样蛋白β状态

阅读:1

Abstract

PURPOSE: This study aimed to identify the effectiveness of free water MRI (FW-MRI) features for predicting amyloid-beta (Aβ) statuses in Alzheimer’s disease (AD) by constructing diagnostic models using machine learning analysis. METHODS: This study retrospectively included 96 patients of mild cognitive impairment (MCI) and AD (69 Aβ-positive and 27 Aβ-negative). Clinical characteristics, FW-corrected and standard diffusion indices, and structural MRI indices were collected. Three supervised machine learning algorithms, including random forest (RF), support vector machine (SVM), and extreme gradient boosting (XGB), were adopted to construct a diagnostic model for distinguishing Aβ deposition in AD. SHapley Additive exPlanation (SHAP) value was used as an interpretable algorithm to identify influential characteristics based on the best-performing model. RESULTS: In the single-modality model, FW-DTI achieved better classification performance than conventional DTI, which obtained accuracies all above 80% among three machine learning approaches on the internal dataset (RF = 0.800, SVM = 0.867, XGB = 0.800). In the multi-modality model, the XGB model integrated FW-DTI, voxel-based morphometry, and clinical features outperformed the RF and SVM models, achieving an accuracy of 86.7% and an area under the curves (AUC) value 93.2% in the training cohort, and an accuracy of 77.8% and AUC value of 83.1% in the external testing cohort. The model demonstrated high sensitivity but relatively low specificity, indicating a tendency toward positive predictions. Furthermore, FW-DTI indices were shown to have the highest predictive value for Aβ deposition. CONCLUSION: Integrating FW-DTI with structural and clinical features effectively differentiated Aβ positivity in AD, with FW-DTI indices contributing the highest predictive risks, demonstrating the potential of FW-DTI in AD diagnosis. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12880-026-02380-6.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。